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It is not uncommon for patients receiving penicillin to develop urticaria.
In most instances this reaction is quite severe and persistent. Keefer and
associates (1) have reported fourteen instances in 500 patients, and Lyons (2)
twelve instances in 209 patients treated with peniciffin. Whether the urticarial
responses are due to penicillin per se or to the incorporated impurities can not
be ascertained until crystalline and absolutely pure penicillin is available. Fein-
berg (3) found that patients who showed positive skin tests to various extracts
of penicillia gave negative skin tests to penicillin. Therefore, it would seem
that there is not necessarily a cross sensitization between the spore and its prod-
ucts.
The findings in urticaria assumed to be due to penicillin cast some doubt on
whether or not these reactions are produced by a true antigen-antibody reaction.
Several investigators have tried to establish such a relationship with varying
results. Lyons (2) was unable to demonstrate positive skin tests or circulating
precipitins in patients who developed urticaria associated with penicillin therapy.
In a patient who had not had urticaria, but who displayed a tuberculin-type of
skin test to crystalline sodium penicillin, Welch and Rostenberg (4) were unable
to demonstrate precipitins in the patient's serum. With some samples of peni-
cillin tested for precipitins with this patient's serum a fine precipitate developed,
but this was also demonstrated with normal control sera. Passive transfer
tests were negative with this patient's serum. Later the same authors (5)
tested 144 individuals who had not had prior contact with penicillin and found
5% to exhibit a positive reaction of the tuberculin type when tested with crys-
talline penicillin sodium intracutaneously. Passive transfer antibodies could
not be demonstrated. In four of these subjects in whom hypersensitivity to
penicillin was not present at the outset, but who exhibited reactions of the Arthus
type following repeated intradermal injections of penicillin (this phenomenon
did not occur following subcutaneous and intramuscular injections of penicillin),
they were unable to demonstrate either passive transfer antibodies or serum
precipitins.
In a case of urticaria associated with penicillin therapy, Criep (6) reported
a positive intracutaneous test, positive passive transfer tests, and precipitins
to penicillin, but anaphylactic antibodies were not demonstrated. Barker (7)
reported a case of urticaria associated with peniciffin therapy with the patient
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exhibiting a positive intracutaneous test to penicillin; and also a patient with
dermatitis venenata attributed to penicillin who showed a positive patch test
to penicillin.
Kolodny and Denhoff (8) performed intradermal tests in 124 patients who
had been treated with penicillin and obtained positive reactions in 21 instances,
7% of which were delayed reactions. Clinical penicillin reactions did not recur
consistently in all patients subsequently given additional therapy. The time
interval between courses of penicillin bore no relationship to the incidence of
clinical reactions in these patients.
McGuire (9) has recently reported a case which seemed to demonstrate a
localized sensitivity to extragenous impurities incorporated with penicillin.
The patient developed a contact dermatitis at the application site of an ointment
containing crude penicillin. This reaction was associated with a disseminated
"id". Subsequently, patch tests to the crude penicillin were positive at the
site of the original contact dermatitis but negative on other parts of the body.
Patch tests with purified penicillin were negative at the site of the original con-
tact dermatitis. Passive transfer tests with blister fluid removed from the area
of the contact dermatitis suggested a transfer of antibodies, but were negative
with serum obtained from the "id" lesions.
McClosky and Smith (10) feel that they have demonstrated penicillin sen-
sitization in guinea pigs. From their experiments, conclusions were drawn that
the antigen-antibody combination is present but lacks permanency and is more
readily reversible than in the case of anaphylactic reactions following bacterial
or protein sensitization.
Often the course of urticaria associated with penicillin therapy is very
bizarre. It may occur at the beginning, several days after institution, or several
days after the termination of therapy. As an example of the bizarre cases
sometimes seen, the following example is described. A patient with primary
syphilis received 2,400,000 units of penicillin over a period of 7 days. On
the 5th day of treatment a severe generalized urticaria appeared. The urticaria
subsided soon after the course of penicillin had been completed. One month
later the patient suffered a cutaneous relapse and was again given penicillin.
During the first three days of therapy, he experienced severe urticaria which
subsided in spite of the fact that penicillin was continued. He was then free
from urticaria for three days although he was given no treatment for the urti-
caria, after which the urticaria recurred and persisted until the course of peni-
ciffin had been completed. Intracutaneous skin tests were negative to two
penicillin preparations with identical lot numbers as those which he received
during the two courses of penicillin therapy.
From the foregoing, it is evident that to date it is an unsettled question as
to whether or not penicillin induces antibody formation in man. We have
studied five patients who developed urticaria associated with penicillin therapy
for evidences of the presence of penicillin antibodies and have obtained the
following data:
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CASES STUDIED
Four of the patients (1, 2, 3, and 4) who were used in this study were among
those included in a previous report (11), on the efficacy of Benadryl.
Case 1: A17 year old white female was given 20,000 units of sodium penicillin every three
hours for sixteen days for "pneumonia". Subsequent studies revealed that she had a pri-
mary atypical pneumonia, and the penicillin was discontinued. There were no apparent
clinical benefits from the penicillin.
Two days after penicillin was discontinued, a mild urticaria developed. Three days
later, the urticaria became severe and at this time the patient was started on 50 milligrams
of Benadryl four times daily. Within four hours after this treatment was started, she was
free from itching and within three days the urticaria had completely subsided.
A review of her past history revealed that she had never previously had urticaria nor any
allergic manifestations. There was no history of allergic stigmata in her family.
Case 2: A 44 year old white man had physical and spinal fluid findings indicative of tabes
dorsalis. His syphilitic infection has been present for twenty-two years. Although his
antisyphilitic treatment had been inadequate, his blood serologic tests for syphilis were
negative.
Two days after completing a course of sodium penicillin therapy consisting of 50,000 units
intramuscularly every three hours for eighty doses (total of 4,000,000 units), he developed a
severe generalized urticaria. He experienced immediate relief with 50 milligrams of Bena-
dryl four times daily. After two days the drug was discontinued for twenty-four hours,
and there was an immediate exacerbation of the urticaria. Benadryl was again resumed
and he was free from urticaria after three additional days of this therapy.
He had never previously had urticaria nor any other allergic tendencies, and there was no
history of allergy in his family.
CaseS: A42 year old white female received 20,000 units of penicillin every three hours for
seven days because of hidroadenitis axillaris. Two days after the penicillin was discon-
tinued, she developed severe generalized urticaria. She was immediately started on 50
milligrams of Benadryl four times a day. After three days the dosage was increased to 300
milligrams each day because of persistence of urticarial lesions. Having received Benadryl
for five days, she was completely free from urticaria although she was extremely drowsy
while on this therapy.
There was no history of urticaria nor other allergic stigmata in the patient or her family.
Case 4: A 21 year old white female developed urtic aria after having received 20,000 units
of sodium penicillin intramuscularly every three hours and daily instillations of a solution
of sodium penicillin into an empyema cavity for two weeks. After two days of urticaria,
she was started on Benadryl, 50 milligrams four times daily with almost immediate relief.
The penicillin therapy was continued for two weeks during which she remained free from
urticaria except when the Benadryl was temporarily stopped for 2 days after having
received the drug for five days.
Case 5: A26 year old white male physician was admitted to the hospital because of severe
impetigo of the face of four days duration. He was started on wet dressings and cremolin
containing 500 units of sodium penicillin per cc. locally. He also received 10,000 units of
sodium penicillin intramuscularly every three hours. On the fourth hospital day the peni-
cillin was increased to 20,000 units every three hours. The impetigo responded satisfac-
torily to treatment but on the eighth hospital day, the patient developed a severe
generalized urticaria with marked angioneurotic edema of the hands and feet. This sub-
sided within five days following the administration of as much as 400 mgms. of Benadryl
daily supplemented by 25 mgms. of ephedrine sulphate by mouth three times daily and
occasional subcutaneous injections of 2 cc. of adrenalin in oil.
Four months previous to admission he had received intramuscular penicillin for 6 days
for an acute exacerbation of bilateral chronic mastoiditis and otitis media.
288 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Two years previously the patient developed acute urticaria while receiving sulfadiazine
for an acute sinus infection. For several months previously he had been treated with in-
sufflations of sulfadiazine powder into the auditory canals for bilateral chronic otitis media.
There had been no other allergic stigmata.
His father is said to have developed asthma while on sulfonamide therapy although he
had no history of respiratory difficulty before or after sulfonamide therapy.
IMMUNOLOGICAL STUDIES
Blood was obtained from all five patients within 24 hours after the urticaria
had completely subsided. At the same time, the patients were tested to sodium
penicillin by the intracutaneous method.
The manufacturer and lot number of the penicillin were known but were dif-
ferent in the case of patients 2 and 5; and were unknown for the other patients.
Penicillin made by the same manufacturer and of the same lot number as that
which patient 2 received was used for the immunological studies of patients
1, 2, 3, and 4. Patient 5 was studied with penicillin identical with that which
he was receiving at the time the urticaria appeared. Serum from a normal,
non-allergic individual who had never received penicillin was used as a control
in these studies.
RESULTS OF SKIN TESTS
Each of the five patients was given intracutaneously 0.05 cc. of a solution
of normal saline containing 20,000 units of sodium penicillin per cc. on the volar
surface of the right forearm and a similar amount of normal saline intracutan-
eously on the volar surface of the left forearm. All of the intracutaneous tests
were negative at 30 minutes, twenty-four hours, and forty-eight hours.
PASSIVE TRANSFER TESTS
Nine non-allergic individuals who had never received penicillin were selected
for these studies. Two of these individuals were injected intracutaneously
on the back with 0.1 cc. of blood serum from each of patients 1, 2, 3, and 4, as
well as 0.1 cc. of normal control blood serum and 0.1 cc. of normal saline. Thirty-
six hours later each site was injected with 0.1 cc. of normal saline containing
10,000 units of sodium penicillin per cc. There was no reaction at any of the
sites within two hours, nor at twenty-four and forty-eight hours.
Two other subjects were tested for the so-called "distant reaction" with blood
serum from each of patients 1, 2, 3, and 4 and serum from the control along with
normal saline as in the above subjects. Thirty-six hours later the two subjects
were given 30,000 units of sodium penicillin intramuscularly into the gluteal
muscles. These two subjects were observed for two hours after the penicillin
injection and at twenty-four and forty-eight hours and no positive reaction was
observed.
Reversed passive transfer tests were employed in two subjects using serum
from patients 1, 2, 3, and 4. This technique consisted of giving two injections
of 30,000 units of penicillin into the gluteal muscles two hours apart. Two
URTICARIA ASSOCIATED WITH PENICILLIN THERAPY 289
hours after the second injection of penicillin each subject was injected intra-
cutaneously on the back with 0.1 cc. of serum from patients 1, 2, 3, and 4 and
the control along with a similar amount of normal saline. These subjects were
observed for two hours, at twenty-four hours, and at forty-eight hours. No
positive reactions were observed.
Three other subjects were tested for passive transfer antibodies (one by the
Prausnitz-Kuestner reaction, one for "distant reactions" and the third by the
reversed passive transfer method) with serum from patient 5 using sodium
penicillin of identical lot number and made by the same manufacturer as that
which he was receiving at the time the urticaria appeared. The same technical
details as described previously were used in the performance of the tests. These
studies also gave negative results.
PRECIPITIN TESTS
Precipitin tests were performed with sera from patients 1, 2, 3, and 4, and
the control using penicillin identical to that which patient 2 was receiving at
the time his urticaria developed. Serum from patient 5 and from the control
were tested against sodium penicillin identical to that which this patient had
received therapeutically. Serum dilutions of 1—10, 1—100, 1—1,000, 1—10,000,
and 1—100,000 were made. Normal saline containing 500, 5,000 and 20,000
units of sodium penicillin per cc. was tested against each serum dilution. In
every instance, including the control tests, a fine precipitate was noted at the
junction of the serum and penicillin solutions. Welch and Rostenberg (4)
have reported a similar experience in the performance of precipitin tests with
many preparations and attribute this phenomena to chemical contaminants.
SIThIMARY AND CONCLUSIONS
1. Five patients who developed urticaria associated with penicillin therapy
were studied for hypersensitivity and for circulating antibodies to sodium peni-
cillin by means of intracutaneous tests, passive transfer tests, (including the
usual Prausnitz-Kuestner reaction, "distant reaction", and reversed passive
transfer test) and precipitin tests. All intracutaneous and passive transfer
tests were negative. The precipitin tests were inconclusive because all dilutions
of sera, including those from a control, showed a fine precipitate at the junction
of the sera and the penicillin solutions.
2. In two patients (Case 2 and 5), we were able to use in the immunological
studies penicillin identical with that which the patients received therapeutically
and to which they had reacted clinically. The immunological studies in these
patients were in no way different from those in three patients who had received
penicillin of which the manufacturer and lot number were unknown.
3. In all instances the urticaria was controlled by Benadryl. Hence, it is
assumed that an excessive amount of histamine was present to account for the
urticaria, but from the studies reported the urticaria cannot be accounted for
on the basis of an antigen-antibody reaction.
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